AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Author's Correction for Zhang et al., Antimicrob. Agents Chemother. 45 (4) 1086-1093.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, K. E.
Right arrow Articles by Webber, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zhang, K. E.
Right arrow Articles by Webber, S.

 Previous Article

Antimicrobial Agents and Chemotherapy, August 2001, p. 2405-2405, Vol. 45, No. 8
0066-4804/01   DOI:
Copyright © 2001, American Society for Microbiology. All rights reserved.

AUTHOR'S CORRECTION

Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities

Kanyin E. Zhang, Ellen Wu, Amy K. Patick, Bradley Kerr, Mark Zorbas, Angela Lankford, Takuo Kobayashi, Yuki Maeda, Bhasker Shetty, and Stephanie Webber

Pfizer Global Research and Development, La Jolla, California, and Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka 569, Japan

Volume 45, no. 4, p. 1086-1093, 2001. Page 1090, column 1, lines 1 to 5: "did not show any ... or its metabolites" should read "showed no significant differences in exposure to either the parent drug or its metabolites between the first dose and steady state (Table 3); however, this analysis was not designed or powered to rule out modest changes in clearance or exposure, and the trend for increased M8-to-nelfinavir concentration ratio on day 28 may reflect modest induction of metabolism during multiple dosing."

Antimicrobial Agents and Chemotherapy, August 2001, p. 2405-2405, Vol. 45, No. 8
0066-4804/01   DOI:
Copyright © 2001, American Society for Microbiology. All rights reserved.



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, K. E.
Right arrow Articles by Webber, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zhang, K. E.
Right arrow Articles by Webber, S.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS